Position in EXEL
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$267,044
New position
Shares Held
4,908
first reported quarter
Ownership
0.002%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Jun 2026
1 quarter on record
Voting authority
Sole 100%
Shared 0%
None 0%
Position in Biotechnology
Healthcare · as of Jun 30, 2026Polar Asset Management Partners Inc. holds $46,847,679 across 12 Biotechnology names. EXEL ranks #4 (0.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | 322,467 | $42,801,044 | |||
| 2 | RNA |
Atrium Therapeutics, Inc.
|
150,000 | $2,017,500 | |
| 3 | RANI |
Rani Therapeutics Holdings, Inc.
|
2,318,542 | $1,762,091 | |
| 4 | EXEL |
Exelixis, Inc.
This page
|
4,908 | $267,044 | |
| 5 | 1,150,300 | $0 | |||
| 6 | 320,529 | $0 | |||
| 7 | OSRH |
OSR Health, Inc.
|
360,000 | $0 | |
| 8 | TVGN |
Tevogen Inc.
|
700,000 | $0 |
All Filings in EXEL
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $267,044 | 4,908 | Shares | Sole | 2026-08-14 | |
| No filing history on record for this holder in this stock. | ||||||